Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05862103

Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort

AMI Survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" (project number 2016YFC1301100) and completed the 1-year visit were followed up by telephone at 3 years (within the corresponding follow-up time window) and 5 years after discharge to acquire the patients' medication, health status, and major adverse cardiovascular and cerebrovascular events, including death, heart failure, rehospitalization, re-myocardial infarction, revascularization, stroke, malignant arrhythmia, and bleeding events.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Acute Myocardial Infarction Adverse Event

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Beijing An Zhen Hospital, Capital Medical University, Beijing, Beijing Municipality, China

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • AMI survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" and completed the 1-year visit.
  • Telephone to obtain informed consent from the subjects/family members of the subjects.

Exclusion criteria

  • Not available

Treatment and study plan

Treatment Strategies

Other

AMI emergency treatment process, pre-reperfusion medication, reperfusion strategy selection, and early cardiac rehabilitation after reperfusion

Primary outcomes

  1. Incidence of MACCE

    Time frame: 5 years after discharge

    the incidence of MACCE (death, heart failure, rehospitalization, re-myocardial infarction, re-myocardial revascularization, stroke, malignant arrhythmia, bleeding events, etc.) in AMI patients

Secondary outcomes

  1. Differences of MACCE between the optimized group and the non-optimized group

    Time frame: 5 years after discharge

    Differences of the MACCE between the optimized group and the non-optimized group

  2. Differences of the MACCE between OCT-guided group and the coronary angiography -guided group

    Time frame: 5 years after discharge

    Differences of the MACCE between OCT-guided group and the coronary angiography -guided group

  3. Differences of MACCE between defer PCI group and direct PCI group

    Time frame: 3 and 5 years after discharge

    Differences of MACCE between defer PCI group and direct PCI group

  4. Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group

    Time frame: 5 years after discharge

    Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group

Study contacts

Contact information is provided by the study sponsor or research team.

Xiling Zhang, MD

CONTACT

[email protected]

+86 13804608748

Sponsors and collaborators

Lead sponsor

Yu Bo

Other

Registry information

Official study title

Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort - a Prospective, Multicenter Study

Important dates

Study start
2022
Primary completion
2025
Study completion
2026
First posted
May 17, 2023
Registry last updated
Sep 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.